These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17410335)

  • 1. Expression of human MCM6 and DNA Topo II alpha in craniopharyngiomas and its correlation with recurrence of the tumor.
    Xu J; Zhang S; You C; Huang S; Cai B; Wang X
    J Neurooncol; 2007 Jun; 83(2):183-9. PubMed ID: 17410335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of minichromosome maintenance protein 6 in craniopharyngioma and its correlation with prognosis].
    Xu JG; You C; Wang XJ; Shuai KG; Wang XS
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):64-7. PubMed ID: 17294730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between clinical characteristics and proliferative activity in patients with craniopharyngioma.
    Losa M; Vimercati A; Acerno S; Barzaghi RL; Mortini P; Mangili F; Terreni MR; Santambrogio G; Giovanelli M
    J Neurol Neurosurg Psychiatry; 2004 Jun; 75(6):889-92. PubMed ID: 15146007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topoisomerase I and IIalpha protein expression in primary colorectal cancer and recurrences following 5-fluorouracil-based adjuvant chemotherapy.
    Tsavaris N; Lazaris A; Kosmas C; Gouveris P; Kavantzas N; Kopterides P; Papathomas T; Agrogiannis G; Zorzos H; Kyriakou V; Patsouris E
    Cancer Chemother Pharmacol; 2009 Jul; 64(2):391-8. PubMed ID: 19083133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Ki-67, topoisomerase IIalpha and c-MYC in astrocytic tumors: correlation with the histopathological grade and proliferative status.
    Faria MH; Gonçalves BP; do Patrocínio RM; de Moraes-Filho MO; Rabenhorst SH
    Neuropathology; 2006 Dec; 26(6):519-27. PubMed ID: 17203587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunohistochemical evaluation of intracranial recurrent meningiomas: correlation of topoisomerase II alpha expression and cell proliferative potential].
    Tanaka M; Kubo O; Tajika Y; Takahashi T; Suzuki S; Takakura K
    No To Shinkei; 1999 Dec; 51(12):1033-9. PubMed ID: 10654298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenesis and cell proliferation in human craniopharyngioma xenografts in nude mice.
    Xu J; You C; Zhang S; Huang S; Cai B; Wu Z; Li H
    J Neurosurg; 2006 Oct; 105(4 Suppl):306-10. PubMed ID: 17328281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferative activity in craniopharyngiomas: clinicopathological correlations in adults and children.
    Raghavan R; Dickey WT; Margraf LR; White CL; Coimbra C; Hynan LS; Rushing EJ
    Surg Neurol; 2000 Sep; 54(3):241-7; discussion 248. PubMed ID: 11118571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human DNA topoisomerase II-alpha: a new marker of cell proliferation in invasive breast cancer.
    Lynch BJ; Guinee DG; Holden JA
    Hum Pathol; 1997 Oct; 28(10):1180-8. PubMed ID: 9343325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical and two-parameter flow cytometric studies of DNA topoisomerase II alpha in human epithelial ovarian carcinoma and germ cell tumor.
    Tanoguchi K; Sasano H; Yabuki N; Kikuchi A; Ito K; Sato S; Yajima A
    Mod Pathol; 1998 Feb; 11(2):186-93. PubMed ID: 9504690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topoisomerase II alpha expression and the Ki-67 labeling index correlate with prognostic factors in estrogen receptor-positive and human epidermal growth factor type-2-negative breast cancer.
    Tokiniwa H; Horiguchi J; Takata D; Kikuchi M; Rokutanda N; Nagaoka R; Sato A; Odawara H; Tozuka K; Oyama T; Takeyoshi I
    Breast Cancer; 2012 Oct; 19(4):309-14. PubMed ID: 21725655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of epithelial cell adhesion molecule and pituitary tumor transforming gene in adamantinomatous craniopharyngioma and its correlation with recurrence of the tumor.
    Tena-Suck ML; Ortiz-Plata A; Galán F; Sánchez A
    Ann Diagn Pathol; 2009 Apr; 13(2):82-8. PubMed ID: 19302955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical study of Ki-67 and DNA topoisomerase II in human endometrium.
    Ito K; Sasano H; Yabuki N; Matsunaga G; Sato S; Kikuchi A; Yajima A; Nagura H
    Mod Pathol; 1997 Apr; 10(4):289-94. PubMed ID: 9110289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA topoisomerase II-alpha and cyclin A immunoexpression in meningiomas and its prognostic significance: an analysis of 263 cases.
    Korshunov A; Shishkina L; Golanov A
    Arch Pathol Lab Med; 2002 Sep; 126(9):1079-86. PubMed ID: 12204057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of the Epstein-Barr virus and DNA-topoisomerase II- α in recurrent and nonrecurrent giant cell lesion of the jawbones.
    Zyada MM; Salama NM
    Biomed Res Int; 2013; 2013():327424. PubMed ID: 23956975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA topoisomerase II-alpha as a proliferation marker in astrocytic neoplasms of the central nervous system: correlation with MIB1 expression and patient survival.
    Holden JA; Townsend JJ
    Mod Pathol; 1999 Dec; 12(12):1094-100. PubMed ID: 10619260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic relevance of topoisomerase II α and minichromosome maintenance protein 6 expression in colorectal cancer.
    Hendricks A; Gieseler F; Nazzal S; Bräsen JH; Lucius R; Sipos B; Claasen JH; Becker T; Hinz S; Burmeister G; Schafmayer C; Schrader C
    BMC Cancer; 2019 May; 19(1):429. PubMed ID: 31072339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA topoisomerase II-alpha as a proliferation marker in human gliomas: correlation with PCNA expression and patient survival.
    Zhao H; Yu H; Liu Y; Wang Y; Cai W
    Clin Neuropathol; 2008; 27(2):83-90. PubMed ID: 18402387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic importance of survivin, Ki-67, and topoisomerase IIα in ovarian carcinoma.
    Kucukgoz Gulec U; Gumurdulu D; Guzel AB; Paydas S; Seydaoglu G; Acikalin A; Khatib G; Zeren H; Vardar MA; Altintas A
    Arch Gynecol Obstet; 2014 Feb; 289(2):393-8. PubMed ID: 23974278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of DNA topoisomerase II-alpha (Ki-S1), p21/Cip-1, and p27/Kip-1 protein immunoexpression in oligodendrogliomas.
    Korshunov A; Golanov A
    Arch Pathol Lab Med; 2001 Jul; 125(7):892-8. PubMed ID: 11419973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.